CD8A and neoplasm: Therefore, we performed targeted next generation sequencing (NGS) and immunohistochemistry (IHC) in a series of ECs, and evaluated the association of POLEm and MMRd with clinicopathologic characteristics, expression of PD-1 and PD-L1, and density of CD3+ and CD8+ tumor-infiltrating lymphocytes (TILs).